Ultragenyx Pharmaceutical Inc. (RARE) SEC filings
RARE SEC filings moved a median of -0.25% by the close. RARE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the RARE overview →
77 measured RARE SEC filing events.
Where these RARE SEC filings landedvs 77 measured RARE SEC filing reactions
| Middle 50% of RARE SEC filing reactions | -1.90% to +2.33% |
|---|---|
| Median reaction (to close) | -0.25% |
| Measured reactions | 77 |
Point-in-time · zero look-ahead
Half of the 77 RARE SEC filing events with a measured close landed between -1.90% and +2.33%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Ultragenyx Pharmaceutica For: Oct 08 | SEC filing · Form 8-K | -1.14% | -0.20% | |
| Form 8-K Ultragenyx Pharmaceutica For: Oct 06 | SEC filing · Form 8-K | +0.14% | +3.04% | |
| Form 8-K Ultragenyx Pharmaceutica For: Sep 17 | SEC filing · Form 8-K | +0.97% | +0.97% | |
| Form 8-K Ultragenyx Pharmaceutica For: Sep 02 | SEC filing · Form 8-K | +0.50% | +6.30% | |
| Form 8-K Ultragenyx Pharmaceutica For: Aug 19 | SEC filing · Form 8-K | -4.01% | -11.00% | |
| Form 8-K Ultragenyx Pharmaceutica For: Aug 07 | SEC filing · Form 8-K | -1.03% | -0.74% | |
| Form 10-Q Ultragenyx Pharmaceutica For: Jun 30 | SEC filing · Form 10-Q | -4.99% | -10.84% | |
| Form 8-K Ultragenyx Pharmaceutica For: Aug 04 | SEC filing · Form 8-K | -4.99% | -10.84% | |
| Form S-8 Ultragenyx Pharmaceutica | SEC filing · Form S-8 | -0.14% | +0.10% | |
| Form 8-K Ultragenyx Pharmaceutica For: May 14 | SEC filing · Form 8-K | -0.23% | -0.41% | |
| Form 10-Q Ultragenyx Pharmaceutica For: Mar 31 | SEC filing · Form 10-Q | +1.24% | +0.08% | |
| Form 8-K Ultragenyx Pharmaceutica For: May 05 | SEC filing · Form 8-K | +1.24% | +0.08% | |
| Form DEFA14A Ultragenyx Pharmaceutica | SEC filing · Form DEFA14A | -0.38% | -0.52% | |
| Form 8-K Ultragenyx Pharmaceutica For: Apr 02 | SEC filing · Form 8-K | +0.43% | +6.65% | |
| Form 8-K Ultragenyx Pharmaceutica For: Mar 30 | SEC filing · Form 8-K | +0.15% | -0.92% | |
| Form ARS Ultragenyx Pharmaceutica For: Dec 31 | SEC filing · Form ARS | +0.15% | -0.92% | |
| Form DEF 14A Ultragenyx Pharmaceutica For: May 14 | SEC filing · Form DEF | +0.15% | -0.92% | |
| Form DEFA14A Ultragenyx Pharmaceutica | SEC filing · Form DEFA14A | +0.15% | -0.92% | |
| Form 8-K Ultragenyx Pharmaceutica For: Mar 12 | SEC filing · Form 8-K | -1.55% | -1.00% | |
| Form 8-K Ultragenyx Pharmaceutica For: Feb 23 | SEC filing · Form 8-K | +1.83% | -1.66% | |
| Form 10-K Ultragenyx Pharmaceutica For: Dec 31 | SEC filing · Form 10-K | -0.22% | +6.96% | |
| Form 8-K Ultragenyx Pharmaceutica For: Feb 12 | SEC filing · Form 8-K | +2.65% | -4.74% | |
| Form 8-K Ultragenyx Pharmaceutica For: Feb 03 | SEC filing · Form 8-K | +1.52% | -0.48% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jan 30 | SEC filing · Form 8-K | +1.24% | -0.25% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jan 12 | SEC filing · Form 8-K | -1.83% | +6.19% | |
| Form 8-K Ultragenyx Pharmaceutica For: Dec 30 | SEC filing · Form 8-K | -2.27% | +2.22% | |
| Form 8-K Ultragenyx Pharmaceutica For: Dec 29 | SEC filing · Form 8-K | -1.86% | +2.07% | |
| Form 10-Q Ultragenyx Pharmaceutica For: Sep 30 | SEC filing · Form 10-Q | +5.45% | +10.28% | |
| Form 8-K Ultragenyx Pharmaceutica For: Nov 03 | SEC filing · Form 8-K | +5.45% | +10.28% | |
| Form 8-K Ultragenyx Pharmaceutica For: Oct 30 | SEC filing · Form 8-K | +1.02% | +2.33% | |
| Form 8-K Ultragenyx Pharmaceutica For: Sep 08 | SEC filing · Form 8-K | -0.41% | -0.10% | |
| Form 8-K Ultragenyx Pharmaceutica For: Aug 18 | SEC filing · Form 8-K | -0.05% | -0.03% | |
| Form 10-Q Ultragenyx Pharmaceutica For: Jun 30 | SEC filing · Form 10-Q | -2.19% | -1.51% | |
| Form 8-K Ultragenyx Pharmaceutica For: Aug 05 | SEC filing · Form 8-K | -2.19% | -1.51% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jul 31 | SEC filing · Form 8-K | +0.92% | +4.79% | |
| Form S-8 Ultragenyx Pharmaceutica | SEC filing · Form S-8 | +0.42% | +0.00% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jul 11 | SEC filing · Form 8-K | +1.25% | +2.45% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jul 09 | SEC filing · Form 8-K | -7.83% | -6.55% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jun 27 | SEC filing · Form 8-K | +0.53% | -2.59% | |
| Form 8-K Ultragenyx Pharmaceutica For: May 15 | SEC filing · Form 8-K | +0.03% | +2.86% | |
| Form 10-Q Ultragenyx Pharmaceutica For: Mar 31 | SEC filing · Form 10-Q | -4.57% | -6.28% | |
| Form 8-K Ultragenyx Pharmaceutica For: May 06 | SEC filing · Form 8-K | -4.57% | -6.28% | |
| Form ARS Ultragenyx Pharmaceutica For: Dec 31 | SEC filing · Form ARS | -1.57% | -1.90% | |
| Form DEF 14A Ultragenyx Pharmaceutica For: May 15 | SEC filing · Form DEF | -1.57% | -1.90% | |
| Form DEFA14A Ultragenyx Pharmaceutica | SEC filing · Form DEFA14A | -1.57% | -1.90% | |
| Form 10-K Ultragenyx Pharmaceutica For: Dec 31 | SEC filing · Form 10-K | -0.18% | +0.23% | |
| Form 8-K Ultragenyx Pharmaceutica For: Feb 13 | SEC filing · Form 8-K | +1.46% | -4.56% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jan 12 | SEC filing · Form 8-K | +2.15% | +5.27% | |
| Form 8-K Ultragenyx Pharmaceutica For: Dec 19 | SEC filing · Form 8-K | -0.05% | +1.19% | |
| Form 8-K Ultragenyx Pharmaceutica For: Nov 09 | SEC filing · Form 8-K | -0.05% | -4.85% | |
| Form 10-Q Ultragenyx Pharmaceutica For: Sep 30 | SEC filing · Form 10-Q | +0.06% | -3.88% | |
| Form 8-K Ultragenyx Pharmaceutica For: Nov 05 | SEC filing · Form 8-K | +0.06% | -3.88% | |
| Form 8-K Ultragenyx Pharmaceutica For: Oct 07 | SEC filing · Form 8-K | -0.38% | -2.60% | |
| Form 8-K Ultragenyx Pharmaceutica For: Oct 03 | SEC filing · Form 8-K | -0.25% | +0.22% | |
| Form 10-Q Ultragenyx Pharmaceutica For: Jun 30 | SEC filing · Form 10-Q | -3.69% | +6.52% | |
| Form 8-K Ultragenyx Pharmaceutica For: Aug 01 | SEC filing · Form 8-K | -3.69% | +6.52% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jul 17 | SEC filing · Form 8-K | +0.80% | -2.37% | |
| Form S-8 Ultragenyx Pharmaceutica | SEC filing · Form S-8 | -1.39% | -1.72% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jun 18 | SEC filing · Form 8-K | +0.44% | -0.73% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jun 13 | SEC filing · Form 8-K | -0.70% | +1.30% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jun 11 | SEC filing · Form 8-K | -1.03% | +4.79% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jun 12 | SEC filing · Form 8-K | +1.69% | +0.42% | |
| Form 8-K Ultragenyx Pharmaceutica For: May 30 | SEC filing · Form 8-K | -0.01% | +1.70% | |
| Form 10-Q Ultragenyx Pharmaceutica For: Mar 31 | SEC filing · Form 10-Q | -0.26% | -4.75% | |
| Form 8-K Ultragenyx Pharmaceutica For: May 02 | SEC filing · Form 8-K | -0.26% | -4.75% | |
| Form ARS Ultragenyx Pharmaceutica For: Dec 31 | SEC filing · Form ARS | +1.39% | -1.12% | |
| Form DEF 14A Ultragenyx Pharmaceutica For: Jun 18 | SEC filing · Form DEF | +1.39% | -1.12% | |
| Form DEFA14A Ultragenyx Pharmaceutica | SEC filing · Form DEFA14A | +1.39% | -1.12% | |
| Form 8-K Ultragenyx Pharmaceutica For: Apr 15 | SEC filing · Form 8-K | -1.05% | -3.75% | |
| Form 10-K Ultragenyx Pharmaceutica For: Dec 31 | SEC filing · Form 10-K | -0.21% | +1.83% | |
| Form S-3ASR Ultragenyx Pharmaceutica | SEC filing · Form S-3ASR | -0.21% | +1.83% | |
| Form 8-K Ultragenyx Pharmaceutica For: Feb 15 | SEC filing · Form 8-K | +0.73% | +4.08% | |
| Form 8-K Ultragenyx Pharmaceutica For: Jan 07 | SEC filing · Form 8-K | -0.14% | +5.15% | |
| Form 8-K Ultragenyx Pharmaceutica For: Dec 15 | SEC filing · Form 8-K | +3.42% | +4.10% | |
| Form 10-Q Ultragenyx Pharmaceutica For: Sep 30 | SEC filing · Form 10-Q | +4.00% | +5.54% | |
| Form 8-K Ultragenyx Pharmaceutica For: Nov 02 | SEC filing · Form 8-K | +4.00% | +5.54% | |
| Form 8-K Ultragenyx Pharmaceutica For: Oct 18 | SEC filing · Form 8-K | -1.44% | -1.99% |
Keep exploring
More RARE: earnings → · analyst actions → · RARE overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Quotient Limited - Ordinary Shares (QTNT) | 982 | -0.13% | 42% |
| PDL BIOPHARMA (PDLI) | 967 | 0.00% | 46% |
| QuidelOrtho Corporation (QDEL) | 965 | +0.02% | 50% |
| Recro Pharma, Inc. (REPH) | 965 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.